Skip to main content
SpringerLink
Log in

Current Research and New Perspectives in Antifungal Drug Development

  • Chapter
  • First Online:
Advances in Microbiology, Infectious Diseases and Public Health

Part of the book series: Advances in Experimental Medicine and Biology ((AMIDPH,volume 1282))

Abstract

In recent times, fungi are becoming more and more active as causal agents of human infections, which is primarily determined by the growing number of people with severe immunosuppression. Thus, the problems of elucidating the mechanisms of action of antifungal preparations, highlighting ways to obtain resistance to their action and research strategies aimed at discovering new compounds with antifungal properties remain the focus of contemporary biomedicine and pharmaceutics. This paper reviews the recent achievements in antifungal drug development and focuses on new natural antifungal remedies with a noticeable effect on pathogens with minimal adverse effects on the host organism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abed R, Dobretsov S, Sudesh K (2009) Applications of cyanobacteria in biotechnology. J Appl Microbiol 106(1):1–12

    CAS  PubMed  Google Scholar 

  • Ansari M, Anurag A, Fatima Z et al (2013) Natural phenolic compounds: a potential antifungal agent. In: Mendez-Vilas A (ed) Microbial pathogens and strategies for combating them: science, technology and education. Formatex Research Center, Badajoz, pp 1189–1195

    Google Scholar 

  • Arif T, Bhosale JD, Kumar N et al (2009) Natural products – antifungal agents derived from plants. J Asian Nat Prod Res 11(7):621–638

    CAS  PubMed  Google Scholar 

  • Baddley JW, Winthrop KL, Patkar NM, Delzell E, Beukelman T, Xie F, Chen L, Curti JR (2011) Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis 17(9):1664–1669

    PubMed  PubMed Central  Google Scholar 

  • Baghi N, Shokohi T, Badali H et al (2016) In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates. Med Mycol 54(7):757–763

    CAS  PubMed  Google Scholar 

  • Battah MG, Ibrahim HAH, El-Naggar MM et al (2014) Antifungal agent from Spirulina maxima: extraction and characterization. GJP 8(2):228–236

    CAS  Google Scholar 

  • Blyth C (2012) Antifungal azoles: old and new. Pediatr Infect Dis J 30(6):506–507

    Google Scholar 

  • Brown G, Denning DW, Cow NA et al (2012) Hidden killers: human fungal infections. Sci Transl Med 4(165):165rv113

    Google Scholar 

  • Brown EM, McTaggart LR, Dunn D, Pszczolko E, Tsui KG, Morris SK, Stephens D, Kus JV, Richardson SE (2018) Epidemiology and geographic distribution of blastomycosis, histoplasmosis, and coccidioidomycosis, Ontario, Canada, 1990-2015. Emerg Infect Dis 24(7):1257–1266

    PubMed  PubMed Central  Google Scholar 

  • Burja A et al (2001) Marine cyanobacteria—a prolific source of natural products. Tetrahedron 57(46):9347–9377

    CAS  Google Scholar 

  • Caggiano G (2012) Fungal infection in patients of paediatric age. In: Oner O (ed) Contemporary pediatrics. Intech, Rijeka, pp 385–402

    Google Scholar 

  • Castillo F, Hernandez D, Gallegos G et al (2012) Antifungal properties of bioactive compounds from plants. In: Dhanasekaran D, Thajuddin N, Annamalai S (eds) Fungicides for plant and animal diseases, Intech, pp 81–106

    Google Scholar 

  • Chandrasekar P (2011) Management of invasive fungal infections: a role for polyenes. J Antimicrob Chemother 66(3):457–465

    CAS  PubMed  Google Scholar 

  • Chowdhary A, Agarwal K, Meis JF (2016) Filamentous fungi in respiratory infections. What lies beyond aspergillosis and mucormycosis? PLoS Pathog 12(4):e1005491

    PubMed  PubMed Central  Google Scholar 

  • Cowen L, Sanglard D, Howard SJ et al (2014) Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med 5(7):a019752

    PubMed  Google Scholar 

  • Cretton S, Dorsaz S, Azzollini A et al (2016) Antifungal quinoline alkaloids from Waltheria indica. J Nat Prod 79(2):300–307

    CAS  PubMed  Google Scholar 

  • Davis S (2005) An overview of the antifungal properties of allicin and its breakdown products – the possibility of a safe and effective antifungal prophylactic. Mycoses 48(2):95–100

    CAS  PubMed  Google Scholar 

  • Debourgogne A, Dorin J, Machouart M (2016) Emerging infections due to filamentous fungi in humans and animals: only the tip of the iceberg? Environ Microbiol Rep 8(3):332–342

    PubMed  Google Scholar 

  • Gatto MA, Sanzani SM, Tradia P et al (2013) Antifungal activity of total and fractionated phenolic extracts from two wild edible herbs. Nat Sci 5(8):895–902

    Google Scholar 

  • Grover N (2010) Echinocandins: a ray of Hope in antifungal drug therapy. Indian J Pharmacol 42(1):9–11

    CAS  PubMed  PubMed Central  Google Scholar 

  • Harrison B, Hashemi J, Bibi M et al (2014) A tetraploid intermediate precedes aneuploid formation in yeasts exposed to fluconazole. PLoS Biology 12:e1001815

    Google Scholar 

  • Havlickova B, Czaika V, Friedrich M (2008) Epidemiological trends in skin mycoses worldwide. Mycoses 51(Suppl. 4):2–15

    PubMed  Google Scholar 

  • Kauffman CA, Pappas PG, Sobel JD, Dismukes WE (eds) (2011) Essential of clinical mycology. Springer, New York/Dordrecht/Heidelberg/London. 542 p

    Google Scholar 

  • Kshetrimayum M, Kant M (2016) Antimicrobial activities of freshwater cyanobacterium, Nostoc sp. from Tamdil Wetland of Mizoram, India: an identification of bioactive compounds by GC-MS. Int J Pharm Sci Res 2(5):199–208

    Google Scholar 

  • Kumar V, Usmani SK, Shrivastava JN (2009) Antifungal activity of Spirulina platensis (Geitler) against some human pathogenic fungi. Int J Plant Res 22(2):83–89

    Google Scholar 

  • Latté K, Kolodziej H (2000) Antifungal effects of hydrolysable tannins and related compounds on dermatophytes, mould fungi and yeasts. Z Naturforsch C 55(5–6):467–472

    PubMed  Google Scholar 

  • Lehrnbecher T, Frank C, Engels K et al (2010) Trends in the postmortem epidemiology of invasive infections at a university hospital. J Infect 61(3):259–265

    CAS  PubMed  Google Scholar 

  • Marichal P, Vanden Bossche H, Odds FC et al (1997) Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 41(10):2229–2237

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mazu TK, Bricker BA, Flores-Rozan H et al (2016) The mechanistic targets of antifungal agents: an overview. Mini-Rev Med Chem 16(7):555–578

    CAS  PubMed  PubMed Central  Google Scholar 

  • Miron D, Battisti F, Silca F et al (2014) Antifungal activity and mechanism of action of monoterpenes against dermatophytes and yeasts. Rev Bras Farm 24(6):660–667

    CAS  Google Scholar 

  • Moraes De Souza M, Prietto L, Ribeiro AC et al (2011) Assessment of the antifungal activity of spirulina platensis phenolic extract against Aspergillus flavus. Ciênc Agrotecnol 35(6):1050–1058

    Google Scholar 

  • Negri M, Salci T, Shinobu-Mesquita C, Capoci I, Svidzinski T, Kioshima E (2014) Early state research on antifungal natural products. Molecules 19(3):2925–2956

    PubMed  PubMed Central  Google Scholar 

  • Ogawa H, Fujimura M, Takeuchi Y et al (2009) Efficacy of itraconazole in the treatment of patients with chronic cough whose sputa yield basidiomycetous fungi-fungus-associated chronic cough (FACC). J Asthma 46(4):407–412

    CAS  PubMed  Google Scholar 

  • Oltu I, Rudic V (2016) Antifungal activity of extracts from Arthrospira platensis against some pathogens, causing invasive mycoses. Curierul Med 59(6):9–14

    Google Scholar 

  • Parks L, Casey W (1996) Fungal sterols. In: Prasad M, Ghannoum M (eds) Lipids of pathogenic fungi. CRC Press, Boca Raton, pp 63–82

    Google Scholar 

  • Perlin D (2015) Mechanisms of Echinocandin antifungal drug resistance. Ann N Y Acad Sci 1354(1):1–11

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pugazhendhi A, Rathinam MM, Sheela JM (2015) Antifungal activity of cell extract of Spirulina platensis against Aflatoxin producing Aspergillus species. Int J Curr Microbiol App Sci 4(8):1025–1029

    CAS  Google Scholar 

  • Rawat D, Bhargava S (2011) Bioactive compounds from Nostoc species. Curr Res Pharm Sci 02:48–54

    Google Scholar 

  • Rodríguez-Leguizamón G, Fiori A, Lagrou K et al (2015) New Echinocandin susceptibility patterns for nosocomial Candida albicans in Bogotá, Colombia, in ten tertiary care centres: an observational study. BMC Infect Dis 15(108):1–7

    Google Scholar 

  • Sanglard D, Coste A, Ferrari S (2009) Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9(7):1029–1050

    CAS  PubMed  Google Scholar 

  • Shaieb F, Issa A, Maragaa A (2014) Antimicrobial activity of crude extracts of cyanobacteria Nostoc commune and Spirulina platensis. Arch Biomed Sci 2(2):34–41

    Google Scholar 

  • Shishido T, Humisto A, Jokela J et al (2015) Antifungal compounds from cyanobacteria. Mar Drugs 13(4):2124–2140

    CAS  PubMed  PubMed Central  Google Scholar 

  • Silva P, Gonçalves S, Santos N (2009) Defensins: antifungal lessons from eukaryotes. Front Microbiol 5:97

    Google Scholar 

  • Singh PK, Kathuria S, Agarwal K et al (2013) Clinical significance and molecular characterization of nonsporulating molds isolated from the respiratory tracts of bronchopulmonary mycosis patients with special reference to basidiomycetes. J Clin Microbiol 51(10):3331–3337

    CAS  PubMed  PubMed Central  Google Scholar 

  • Subissi A, Monti D, Togni G et al (2010) Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. Drugs 70(16):2133–2152

    PubMed  Google Scholar 

  • Uniyal V, Bhatt RP, Saxena S et al (2012) Antifungal activity of essential oils and their volatile constituents against respiratory tract pathogens causing Aspergilloma and Aspergillosis by gaseous contact. J Nat Appl Sci 4(1):65–70

    CAS  Google Scholar 

  • Uyisenga J, Nzayino P, Seneza R et al (2010) In vitro study of antibacterial and antifungal activity of Spirulina platensis. Int J Ecol Dev 16(2):10S–15S

    Google Scholar 

  • Velayuthan R, Samudi C, Lakhbeer Singh H, Ng K, Shankar E, Denning D (2018) Estimation of the burden of serious human fungal infections in Malaysia. J Fungi 4(1):38

    Google Scholar 

  • Vestola J, Shishido TK, Jokela J et al (2014) Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway. PNAS 111:E1909–E1917

    CAS  PubMed  Google Scholar 

  • Volk R, Franz H (2006) Antialgal, antibacterial and antifungal activity of two metabolites produced and excreted by cyanobacteria during growth. Microbiol Res 161(2):180–186

    CAS  PubMed  Google Scholar 

  • Wang J, He W, Huang X et al (2016) Antifungal new Oxepine-containing alkaloids and Xanthones from the Deep-Sea-Derived fungus Aspergillus versicolor SCSIO 05879. J Agric Food Chem 64(14):2910–2916

    CAS  PubMed  Google Scholar 

  • Zerbo P, Konate K, Ouedraogo M et al (2014) Antioxidant and antifungal profiles of phenol acid rich-fractions from Sida urens l. Against mycelia growth inhibition of some aspergillus and fusarium species. Int J Pharm Pharm Sci 6(1):174–178

    Google Scholar 

Download references

Compliance with Ethical Standards

Conflict of Interest: Author Iulian Oltu declares that he has no conflict of interest. Author Liliana Cepoi declares that she has no conflict of interest. Author Valeriu Rudic declares that he has no conflict of interest. Author Ludmila Rudi declares that she has no conflict of interest. Author Tatiana Chiriac declares that she has no conflict of interest. Author Ana Valuta declares that she has no conflict of interest. Author Svetlana Codreanu declares that she has no conflict of interest.

Ethical Approval: This article does not contain any studies with human participants or animals performed by any of the authors.

Author information

Authors and Affiliations

  1. Hospital of Dermatology and Communicable Diseases, Chisinau, Republic of Moldova

    Iulian Oltu

  2. Institute of Microbiology and Biotechnology, Chisinau, Republic of Moldova

    Liliana Cepoi, Valeriu Rudic, Ludmila Rudi, Tatiana Chiriac, Ana Valuta & Svetlana Codreanu

Authors
  1. Iulian Oltu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liliana Cepoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valeriu Rudic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ludmila Rudi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tatiana Chiriac
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ana Valuta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Svetlana Codreanu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Svetlana Codreanu .

Editor information

Editors and Affiliations

  1. Microbial Biofilm Laboratory, Fondazione Santa Lucia IRCCS, Rome, Italy

    Gianfranco Donelli

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Oltu, I. et al. (2019). Current Research and New Perspectives in Antifungal Drug Development. In: Donelli, G. (eds) Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology(), vol 1282. Springer, Cham. https://doi.org/10.1007/5584_2019_453

Download citation

Publish with us

Policies and ethics

Search

Navigation